# Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/biomarker-analyses-in-the-phase-iii-ascent-study-of-sacituzumab-govitecan-versus/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Aditya Bardia,Sara M. Tolaney,Kevin Punie,Delphine Loirat,Mafalda Oliveira,Kevin Kalinsky,Amelia Zelnak,Philippe Aftimos,Florence Dalenc,Sagar Sardesai,Erika Hamilton,Priyanka Sharma,Sabela Recalde,Eva Ciruelos Gil,T Traina,Joyce O’Shaughnessy,Javier Cortés,Mu‐Hung Tsai,Linda T. Vahdat,Véronique Dièras,Lisa A. Carey,Hope S. Rugo,David M. Goldenberg,Q. Hong,Martin Olivo,Loretta M. Itri,Sara A. Hurvitz |
| Citations | 308 |
| DOI | 10.1016/j.annonc.2021.06.002 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.annalsofoncology.org/article/S0923753421020470/pdf |
| OpenAlex ID | https://openalex.org/W3169973594 |
| PMID | 34116144 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Lisa A. Carey](https://scholariq.org/researchers/lisa-a-carey/)
- [Philippe Aftimos](https://scholariq.org/researchers/philippe-aftimos/)

## Paper journal

- [Annals of Oncology](https://scholariq.org/journals/annals-of-oncology/)

## Paper primary topic

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)

## Paper topics

- [HER2/EGFR in Cancer Research](https://scholariq.org/topics/her2-egfr-in-cancer-research/)
- [Advanced Breast Cancer Therapies](https://scholariq.org/topics/advanced-breast-cancer-therapies/)
- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.